nach oben

Erschienen in:

20.11.2018 | Original Article

Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran

verfasst von: Aryan Esmaeili, Mostafa Shokoohi, Ahmad Danesh, Hamid Sharifi, Mohammad Karamouzian, AliAkbar Haghdoost, Armita Shahesmaeili, Samaneh Akbarpour, Meghan D. Morris, Ali Mirzazadeh

Erschienen in: AIDS and Behavior | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

We used two national surveys (2010: N = 1597; 2013: N = 1057) of people who inject drugs (PWID) in past-month to assess the prevalence and population size of PWID with either safe or unsafe injection and sex behaviors, overall and by HIV status. In 2013, only 27.0% (vs. 32.3% in 2010) had safe injection and sex, 24.6% (vs. 23.3% in 2010) had unsafe injection and sex, 26.4% (vs. 26.5% in 2010) had only unsafe injection, and 22.0% (vs. 18.0% in 2010) had unsafe sex only. Among HIV-positive PWID in 2013, only 22.1% (~ 2200 persons) had safe injection and sex, 14.2% (~ 1400 persons) had unsafe injection and sex, 53.1% (~ 5200 persons) had unsafe injection, and 10.6% had unsafe sex (~ 1100 persons). Among HIV-negative PWID in 2013, only 27.5% (~ 22,200 persons) had safe injection and sex, 25.9% (~ 20,900 PWID) had unsafe injection and sex, 23.2% (~ 18,700 persons) had unsafe injection, and 23.3% (~ 18,800 persons) had unsafe sex. HIV-positive and -negative PWID in Iran continue to be at risk of HIV acquisition or transmission which calls for targeted preventions services.

Nur mit Berechtigung zugänglich

Kim NJ, et al. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012. Int J Drug Policy. 2015;26(12):1238–43.CrossRefPubMed

Khajehkazemi R, et al. HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sex Transm Infect. 2013;89(Suppl 3):iii29-32.CrossRefPubMed

National AIDS Committee Secretariat. Islamic Republic of Iran AIDS Progress Report (http://www.unaids.org/sites/default/files/country/documents/IRN_narrative_report_2015.pdf). In: office HS, editor. Tehran: Ministry of Health and Medical Education. 2015.

Nikfarjam A, et al. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. Int J Drug Policy. 2016;31:147–52.CrossRefPubMed

Malta M, et al. HIV prevalence among female sex workers, drug users and men who have sex with men in Brazil: a systematic review and meta-analysis. BMC Public Health. 2010;10:317.CrossRefPubMedPubMedCentral

Lopez LM, et al. Behavioral interventions for improving condom use for dual protection. Cochrane Database Syst Rev. 2013;10:CD010662.

Malekinejad M, et al. Effectiveness of community-based condom distribution interventions to prevent HIV in the United States: a systematic review and meta-analysis. PLoS ONE. 2017;12(8):e0180718.CrossRefPubMedPubMedCentral

Thiede H, et al. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007;91(Suppl 1):S39–47.CrossRefPubMed

Herbst JH, et al. A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. J Acquir Immune Defic Syndr. 2005;39(2):228–41.PubMed

10.

Huang Q, et al. Prevalence of HIV infection and syphilis, sexual behaviors and awareness of HIV/AIDS related knowledge among men who have sex with men in China: a Meta-analysis of data collected from 2010 to 2013. Zhonghua Liu Xing Bing Xue Za Zhi. 2015;36(11):1297–304.PubMed

11.

Chow EP, et al. Behavioral interventions improve condom use and HIV testing uptake among female sex workers in China: a systematic review and meta-analysis. AIDS Patient Care STDS. 2015;29(8):454–60.CrossRefPubMed

12.

Copenhaver MM, et al. Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abuse Treat. 2006;31(2):163–71.CrossRefPubMedPubMedCentral

13.

Amin-Esmaeili M, et al. Profile of people who inject drugs in Tehran, Iran. Acta Med Iran. 2016;54(12):793–805.PubMed

14.

Arruda MM, et al. Sensitivity and specificity of parallel or serial serological testing for detection of canine Leishmania infection. Mem Inst Oswaldo Cruz. 2016;111(3):168–73.CrossRefPubMedPubMedCentral

15.

Treloar C, Wilson H, Mao L. Deconstructing injecting risk of hepatitis C virus transmission: using strategic positioning to understand “higher risk” practices. Drugs: Education, Prevention and Policy. 2016;23(6):457–61.

16.

Ministry of Health and Medical Education. AIDS Progress Report on Monitoring of the United Nations General Assembly Special Session on HIV and AIDS (https://goo.gl/7xeeVZ). Tehran: National AIDS Committee Secretariat, Ministry of Health and Medical Education, Islamic Republic of Iran.; March 2015.

17.

Shokoohi M, et al. Low HIV testing rate and its correlates among men who inject drugs in Iran. Int J Drug Policy. 2016;32:64–9.CrossRefPubMed

18.

Kennedy CE, et al. Behavioural interventions for HIV positive prevention in developing countries: a systematic review and meta-analysis. Bull World Health Organ. 2010;88(8):615–23.CrossRefPubMedPubMedCentral

19.

Noroozi A, et al. Impact of HIV status notification on risk behaviors among men who inject drugs in Kermanshah, West of Iran. J Res Health Sci. 2016;16(3):116–21.PubMed

20.

Radfar SR, et al. Behaviors influencing human immunodeficiency virus transmission in the context of positive prevention among people living with HIV/acquired immunodeficiency syndrome in Iran: a qualitative study. Int J Prev Med. 2014;5(8):976–83.PubMedPubMedCentral

21.

Radfar SR, Nematollahi P, Arasteh M. Factors influencing access and use of care and treatment services among iranian people living with HIV and AIDS: a qualitative study. Iran J Public Health. 2016;45(1):109–11.PubMedPubMedCentral

22.

Mgbere O, et al. System and patient barriers to care among people living with HIV/AIDS in Houston/Harris County, Texas: HIV Medical Care Providers’ Perspectives. J Int Assoc Provid AIDS Care. 2015;14(6):505–15.CrossRefPubMed

23.

Noroozi M, et al. Injecting and sexual networks and sociodemographic factors and dual HIV risk among people who inject drugs: a cross-sectional study in Kermanshah Province, Iran. Addict Health. 2016;8(3):186–94.PubMedPubMedCentral

24.

Rahimi-Movaghar A, et al. HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007. Int J Drug Policy. 2012;23(4):271–8.CrossRefPubMed

25.

Nasirian M, et al. Modeling of human immunodeficiency virus modes of transmission in Iran. J Res Health Sci. 2012;12(2):81–7.PubMed

26.

Guise A, Albers ER, Strathdee SA. ‘PrEP is not ready for our community, and our community is not ready for PrEP’: pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response. Addiction. 2017;112(4):572–8.CrossRefPubMed

27.

Bernard CL, et al. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: a model-based analysis. PLoS Med. 2017;14(5):e1002312.CrossRefPubMedPubMedCentral

28.

Fu R, Owens DK, Brandeau ML. Cost-effectiveness of alternative strategies for provision of HIV pre-exposure prophylaxis for people who inject drugs. AIDS. 2018;32(5):663–72.PubMedPubMedCentral

29.

Alipour A, et al. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010. Sex Transm Infect. 2013;89(Suppl 3):iii41-4.CrossRefPubMed

30.

Bandali S. Norms and practices within marriage which shape gender roles, HIV/AIDS risk and risk reduction strategies in Cabo Delgado, Mozambique. AIDS Care. 2011;23(9):1171–6.CrossRefPubMed

31.

Mtenga SM, et al. ‘It is not expected for married couples’: a qualitative study on challenges to safer sex communication among polygamous and monogamous partners in southeastern Tanzania. Glob Health Action. 2016;9:323–6.CrossRef

32.

Pinchoff J, et al. Why don’t urban youth in Zambia use condoms? The influence of gender and marriage on non-use of male condoms among young adults. PLoS ONE. 2017;12(3):e0172062.CrossRefPubMedPubMedCentral

33.

Maia C, Guilhem D, Freitas D. Vulnerability to HIV/AIDS in married heterosexual people or people in a common-law marriage. Rev Saude Publica. 2008;42(2):242–8.CrossRefPubMed

34.

Raymond E, Trussell J. Condom use within marriage: a neglected HIV intervention. Bull World Health Organ. 2005;83(3):239.PubMedPubMedCentral

35.

Wand H, et al. Individual and population level impacts of illicit drug use, sexual risk behaviours on sexually transmitted infections among young Aboriginal and Torres Strait Islander people: results from the GOANNA survey. BMC Public Health. 2016;16:600.CrossRefPubMedPubMedCentral

36.

Hoenigl M, et al. Clear links between starting methamphetamine and increasing sexual risk behavior: a cohort study among men who have sex with men. J Acquir Immune Defic Syndr. 2016;71(5):551–7.CrossRefPubMedPubMedCentral

37.

Shoptaw S, Reback CJ. Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction. 2007;102(Suppl 1):130–5.CrossRefPubMed

38.

Noroozi A, Malekinejad M, Rahimi-Movaghar A. Factors influencing transition to Shisheh (Methamphetamine) among young people who use drugs in Tehran: a qualitative study. J Psychoactive Drugs. 2018;50(3):214–23.CrossRefPubMed

39.

Rahimi-Movaghar A, et al. Use of stimulant substances among university students in tehran: a qualitative study. Iran J Psychiatry Behav Sci. 2011;5(2):32–42.PubMedPubMedCentral

40.

Fallah G, et al. Stimulant use in medical students and residents requires more careful attention. Caspian J Intern Med. 2018;9(1):87–91.PubMedPubMedCentral

41.

Alam-Mehrjerdi Z, Abdollahi M. The Persian methamphetamine use in methadone treatment in Iran: implication for prevention and treatment in an upper-middle income country. Daru. 2015;23:51.CrossRefPubMedPubMedCentral

42.

Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran. Int J Drug Policy. 2013;24(6):e115–6.CrossRefPubMed

43.

Hurtado Navarro I, et al. Differences between women and men in serial HIV prevalence and incidence trends. Eur J Epidemiol. 2008;23(6):435–40.CrossRefPubMed

44.

Viitanen P, et al. Hepatitis A, B, C and HIV infections among finnish female prisoners—young females a risk group. J Infect. 2011;62(1):59–66.CrossRefPubMed

45.

Tracy D, et al. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort. BMJ Open. 2014;4(5):e004988.CrossRefPubMedPubMedCentral

46.

Montgomery SB, et al. Gender differences in HIV risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse. 2002;28(3):453–75.CrossRefPubMed

47.

Des Jarlais DC, et al. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend. 2012;124(1–2):95–107.CrossRefPubMedPubMedCentral

48.

Jin H, et al. Differences in HIV risk behaviors among people who inject drugs by gender and sexual orientation, San Francisco, 2012. Drug Alcohol Depend. 2014;145:180–4.CrossRefPubMed

Titel: Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran
verfasst von: Aryan Esmaeili
Mostafa Shokoohi
Ahmad Danesh
Hamid Sharifi
Mohammad Karamouzian
AliAkbar Haghdoost
Armita Shahesmaeili
Samaneh Akbarpour
Meghan D. Morris
Ali Mirzazadeh
Publikationsdatum: 20.11.2018
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 6/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-018-2345-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Krebspatienten impfen: Was? Wen? Und wann nicht?

Nierenultraschall: Tipps vom Profi

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

„KI sieht, was wir nicht sehen“

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2019

Syndemic Experiences, Protective Factors, and HIV Vulnerabilities Among Lesbian, Gay, Bisexual and Transgender Persons in Jamaica

HIV Prevalence Among Tuberculosis Patients in Sub-Saharan Africa: A Systematic Review and Meta-analysis

The Intersection of HIV, Social Vulnerability, and Reproductive Health: Analysis of Women Living with HIV in Rio de Janeiro, Brazil from 1996 to 2016

Coital Frequency and Male Concurrent Partnerships During Pregnancy and Postpartum in Agbogbloshie, Ghana

Rectal Douching Practices Associated with Anal Intercourse: Implications for the Development of a Behaviorally Congruent HIV-Prevention Rectal Microbicide Douche

Role of Social Network Sexual Norms and Behaviors on the HIV Sexual Risk Behaviors of People Who Inject Drugs in HPTN 037

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Krebspatienten impfen: Was? Wen? Und wann nicht?

Nierenultraschall: Tipps vom Profi

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

„KI sieht, was wir nicht sehen“

Update Innere Medizin